Physician profile
Thomas Weber
NPI 1487628723
$812.24
in general payments reported to CMS, 2019-2025
11 companies · $32.90 in 2025
The $32.90 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.63 · 2020: $19.44 · 2021: $289 · 2022: $345 · 2024: $83.16 · 2025: $32.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $228.98 | 2021-2022 | |
| Painteq LLC | $139.82 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $103.02 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $102.02 | 2022 | |
| Lundbeck LLC | $93.64 | 2024-2025 | Vyepti |
| Astrazeneca Pharmaceuticals Lp | $42.63 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.36 | 2022 | |
| Abbvie INC. | $23.37 | 2021 | |
| Valinor Pharma, LLC | $22.42 | 2024 | Movantik |
| Lilly USA, LLC | $15.49 | 2021 | |
| Redhill Biopharma INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.